Ayala Healthcare Holdings Inc., a wholly-owned unit of conglomerate Ayala Corp., acquired 100 percent of Healthway, one of the leading clinic networks in the country, for an undisclosed amount.
Ayala Corp. said in a disclosure to the stock exchange Friday it bought Healthway from Hong-Kong based HKR International (HKRI) Ltd., a diversified company with investments throughout Asia in real estate, hospitality and healthcare.
“We are very pleased to welcome Healthway to AC Health and the Ayala group. The Healthway name has become synonymous with quality healthcare and has been well-regarded among patients and medical professionals. We intend to build on this further, as we integrate Healthway with our AC Health portfolio,” said Ayala president Fernando Zobel de Ayala.
AC Health said Healthway’s seven mall-based multi-specialty clinics and 40 corporate clinics would expand the group’s clinic portfolio that included 70 FamilyDOC community-based primary care clinics and 10 corporate clinics.
“We at Healthway are very proud to join the AC Health family. Over the years, we have worked hard to establish Healthway as one of the leading and most preferred healthcare providers in the country, and we look forward to becoming even stronger now that we are part of a broader network,” said Sidney Hui, president and chief executive of Healthway Philippines.
Since it began operations in 1998, Healthway has served over two million patients. It has a network of around 800 doctors across different specialties.
Its branches are located in SM North EDSA, Festival Mall, Alabang Town Center, Adriatico Manila, Shangri-La Mall, Market-Market and Greenbelt 5. Jenniffer B. Austria
The clinics offer a comprehensive range of out-patient services, including specialty consults, imaging, laboratory, specialized diagnostics, ambulatory surgical services, dental services and physical therapy.
AC Health president Paolo Borromeo said aside from expanding the clinic count and patient base, the acquisition allowed the company to serve different types of patients across multiple clinic formats, whether it be in primary care, multi-specialty care or corporate clinics.
“We see many opportunities for synergy, including patient referrals, sharing of medical professionals and integration of diagnostics and pharmacy services,” Borromeo said.
The acquisition follows another recent investment. AC Healthcare obtained a minority stake in IE Medica, a major pharmaceutical importer, and MedEthix, its affiliated distribution company.
Borromeo said the group was finalizing a joint-venture partnership with an international cancer center operator for their specialty cancer hospital, which is scheduled to open in 2022.
“This is an exciting time for us at AC Health. Taken together, all of these investments bring us closer to realizing our vision of an integrated healthcare ecosystem. We are still looking to grow our portfolio further, particularly in retail pharma, financing, and hospitals. Ultimately, our goal is to touch the lives of 1 in 5 Filipinos by 2030,” added Borromeo.